Similarly, lepodisiran has shown well-tolerated and dose-dependent reductions in serum Lp(a) concentrations, with a Phase III trial currently recruiting participants and expected to be completed by 2029 (NCT06292013 and NCT04914546)
(3) Yue X, Liu SL, Guo JN, Meng TG, Zhang XR, Li HX, Song CY, Wang ZB, Schatten H, Sun QY, Guo XP
Classic manifestations include hypermobile joints (joints that move excessively and dislocate easily), skin hyperextensibility (unusually stretchy, fragile skin), and tissue fragility such as easy bruising and poor wound healing
doi: 10.4172/2157-7439.1000522 220
Serving Size: 1 Vegetable Capsule, Servings Per Container: 100. Amount Per Serving % DV, Acetyl-L-Carnitine (from N-Acetyl-Carnitine HCl) 500 mg*, *Daily Value (DV) not established
KuchtaRKoodziej-SobociskaMBrabecJMocickiDSaamatinRScholzT